REFERENCES Brinton LA, Hoover RN (the Endometrial Cancer Collaborative Group): Estrogen replacement therapy and endometrial cancer risk: Unresolved issues. Obstet Gynecol 81:265-271, 1993. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development: Combination oral contraceptive use and the risk of endometrial cancer. JAMA 257:796-800, 1987. Elwood JM, Cole P, Rothman KJ, et al.: Epidemiology of endometrial cancer. J Natl Cancer Inst 59:1055-1060, 1977. Henderson BE, Casagrande JT, Pike MC, et al.: The epidemiology of endometrial cancer in young women. Br J Cancer 47:749-756, 1983. Hulka BS, Fowler WC, Kaufman DG, et al.: Estrogen and endometrial cancer: Cases and two control groups from North Carolina. Am J Obstet Gynecol 137:92-101, 1980. Potischman N, Swanson CA, Brinton LA, et al.: Dietary associations in a case-control study of endometrial cancer. Cancer Causes Control 4:239-250, 1993. Ries LAG, Miller BA, Hankey BF, et al.: SEER Cancer Statistics Review, 1973-1991: Tables and Graphs, National Cancer Institute. NIH Publ. No. 94-2789, Bethesda, MD, 1994. Shapiro S, Kelly JP, Rosenberg L, et al.: Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 313:969-972, 1985. Swanson CA, Potischman N, Wilbanks GD, et al.: Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarker Prev 2:321-327, 1993. Weiss NS and Sayvetz TA: Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med 302:551-554, 1980. Weiss NS, Szekely DR and Austin DF: Increasing incidence of endometrial cancer in the United States. N Engl J Med 294:1259-1262, 1976.

---